Status:
COMPLETED
Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia
Lead Sponsor:
AstraZeneca
Conditions:
Dyslipidaemia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the All-Russian Scientific Cardiology Society guid...
Eligibility Criteria
Inclusion
- Subject must be 18 years of age or older of either gender or race.
- Subject must provide informed consent and comply with the survey procedures.
- Subject is on lipid lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.
Exclusion
- Subjects who are unwilling or unable to provide informed consent
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01221584
Start Date
October 1 2010
End Date
March 1 2011
Last Update
March 1 2012
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Krasnodar, Russia
2
Research Site
Moscow, Russia
3
Research Site
Nizhny Novgorod, Russia
4
Research Site
Novosibirsk, Russia